|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K2039/505 | (2013.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| C07K2317/56 | (2013.01) | ||
| A61P 19/02 | (2006.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K 16/24 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 16/245 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3332807 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17199544.2 |
| Date of filing the European patent application | 2006-10-24 | |
| (97) | Date of publication of the European application | 2018-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-02-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 730435 P | 2005-10-26 | US | |
| 742125 P | 2005-12-02 | US |
| (72) |
Lowe, Phil , CH
Gram, Hermann , DE
Jung, Thomas , CH
Wright, Timothy , US
Mundel, Trevor , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF ANTI IL-1BETA ANTIBODIES |
| USE OF ANTI IL-1BETA ANTIBODIES |